Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction

被引:36
作者
Galve, E
Mallol, A
Catalan, R
Palet, J
Méndez, S
Nieto, E
Diaz, A
Soler-Soler, J
机构
[1] Hosp Gen Hosp Hebron, Serv Cardiol, Barcelona 08035, Spain
[2] Hosp Gen Univ Hebron, Serv Bioquim, Barcelona, Spain
关键词
heart failure; diuretics; neurohumoral activation;
D O I
10.1016/j.ejheart.2004.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Loop diuretics are beneficial in heart failure in the short term because they eliminate fluid retention, but in the long-term, they could adversely influence prognosis due to activation of neurohumoral mechanisms. Aims: To explore the changes induced by diuretic withdrawal in chronic nonadvanced heart failure. Methods: Diuretics were withdrawn in 26 stabilized heart failure patients with systolic dysfunction (ejection fraction [EF]< 45%). Clinical status was evaluated by physical exam, exercise capacity (corridor test) and New York Heart Association (NYHA) class. Biochemical and neurohumoral determinations were performed at baseline and at 3 months. Results: At 3 months, 17 out of 26 patients (65%) were able to tolerate diuretic interruption without a deterioration in exercise capacity or New York Heart Association functional class. Renal function parameters improved (baseline urea 46.2 +/- 10.8 to 39.2 +/- 10.1 mg/dl at 3 months, p=0.014; creatinine 1.1 +/- 0.23 to 0.98 +/- 0.2 mg/dl, p=0.013). Glucose metabolism also improved (fasting glucose 151 91 to 122 +/- 14 mg/dl, p=0.035). Heart rate and systolic blood pressure did not significantly change, while diastolic blood pressure increased (from 80 +/- 10 to 87 +/- 13 mm Hg, p=0.006). Neurohumoral determinations showed a decrease in plasma renin activity (4.19 +/- 5.96 to 2.88 +/- 4.98 ng/ml, p=0.026), with no changes in aldosterone, arginine-vasopressin, endothelin-1 and norepinephrine. In contrast, atrial natriuretic peptide significantly increased (115 +/- 87 to 168 +/- 155 pg/ml, p=0.004). Conclusion: Diuretic withdrawal in stabilized heart failure with systolic dysfunction is associated with an improvement in renal function parameters, glucose metabolism and some neurohumoral parameters, such as plasma renin activity; however, atrial natriuretic peptide levels increased. (c) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:892 / 898
页数:7
相关论文
共 50 条
[21]   Decreased survival in diabetic patients with heart failure due to systolic dysfunction [J].
Kamalesh, M ;
Subramanian, U ;
Sawada, S ;
Eckert, G ;
Temkit, M ;
Tierney, W .
EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (04) :404-408
[22]   Is diuretic withdrawal safe in patients with heart failure and reduced ejection fraction? A retrospective analysis of our outpatient cohort [J].
Romano, Giuseppe ;
Vitale, Giuseppe ;
Bellavia, Diego ;
Agnese, Valentina ;
Clemenza, Francesco .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 42 :E11-E13
[23]   Effects of Triamterene in Hospitalized Patients with Heart Failure and Diuretic Resistance: A Randomized Clinical Trial [J].
Taban-Sadeghi, Mohammadreza ;
Khani, Elnaz ;
Khezripour, Kimia ;
Enamzadeh, Elgar ;
Safaei, Naser ;
Entezari-Maleki, Taher .
JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (12) :1352-1358
[24]   Flexible Diuretic Titration in Chronic Heart Failure: Where Is the Evidence? [J].
Piano, Mariann R. ;
Prasun, Marilyn A. ;
Stamos, Thomas ;
Groo, Vicki .
JOURNAL OF CARDIAC FAILURE, 2011, 17 (11) :944-954
[25]   The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction [J].
Lipinski, MJ ;
Vetrovec, GW ;
Gorelik, D ;
Froelicher, VF .
JOURNAL OF CARDIAC FAILURE, 2005, 11 (08) :624-630
[26]   Clinical Significance of Endogenous Vasoactive Neurohormones in Chronic Systolic Heart Failure [J].
Tang, W. H. Wilson ;
Shrestha, Kevin ;
Martin, Maureen G. ;
Borowski, Allen G. ;
Jasper, Sue ;
Yandle, Timothy G. ;
Richards, A. Mark ;
Klein, Allan L. ;
Troughton, Richard W. .
JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) :635-640
[27]   Diuretic resistance in patients with heart failure: Clinical characteristics and predictors of outcome [J].
Tasew, Mesfin ;
Aklilu, Tamirat Moges ;
Abdissa, Senbeta Guteta .
JOURNAL OF CLINICAL SCIENCES, 2020, 17 (03) :66-73
[28]   Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure [J].
Bonfils, Peter K. ;
Damgaard, Morten ;
Taskiran, Mustafa ;
Goetze, Jens Peter ;
Norsk, Peter ;
Gadsboll, Niels .
EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (09) :995-1001
[29]   Inflammation and endothelial dysfunction in patients with chronic heart failure [J].
Greig, Douglas ;
Castro, Pablo ;
Gabrielli, Luigi ;
Miranda, Rodrigo ;
Verdejo, Hugo ;
Alcaino, Hernan ;
Bustos, Carlos ;
Chiong, Mario ;
Godoy, Ivan ;
Mellado, Rosemarie ;
Garcia, Lorena ;
Salas, Daniela ;
Vivar, Raul ;
Vukasovic, Jose Luis ;
Concepcion, Roberto ;
Diaz-Araya, Guillermo .
REVISTA MEDICA DE CHILE, 2008, 136 (06) :687-693
[30]   Bone marrow dysfunction in chronic heart failure patients [J].
Westenbrink, B. Daan ;
Voors, Adriaan A. ;
de Boer, Rudolf A. ;
Schuringa, Jan J. ;
Klinkenberg, Theo ;
van der Harst, Pim ;
Vellenga, Edo ;
van Veldhuisen, Dirk J. ;
van Gilst, Wiek H. .
EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (07) :676-684